In response to makindatcash.. why two new subs ... well it has to do with Legal so Charles knows why and I would imagine it is in his background of Patent Law and Intellectual Property Protection .. he is smarter than us.
But it is going through Enzolytics ENZC " THE COMPANY"
--
Formation of Two New Wholly-Owned Subsidiaries
Pursuant to the terms of the Business Combination Agreement, on November 24, 2020, the
Company [/b]formed two new Texas corporations as wholly-owned subsidiaries for the purpose of
licensing certain patented technologies: Biogenysis, Inc. and Virogentics, Inc.
Two Patent License Agreements
-
On November 30, 2020, Biogenysis, Inc., a wholly-owned subsidiary of Enzolytics, Inc., entered
into a Patent License Agreement with Bioclonetics in order to license the U.S. Provisional Patent
Application No. 63/078,482, filed September 15, 2020, entitled NOVEL HIV-BINDING
PEPTIDES for treating, preventing and reducing the risks of HIV, including all patents issuing
therefrom and any foreign counterparts thereof.
-
Also on November 30, 2020, Virogentics, Inc., a wholly-owned subsidiary of Enzolytics, Inc.,
entered into a Patent License Agreement with the Zhabilov Trust in order to license the U.S. Patent
No. 7,479538, entitled Irreversibly - Inactivated pepsinogen fragment and Pharmaceutical
composition the same for detecting preventing and treating HIV; U.S. Patent No. 8,066982,
Irreversibly - Inactivated pepsinogen fragment and Pharmaceutical composition compressing the
same for detecting preventing and treating HIV, including all patents issuing therefrom and any
foreign counterparts thereof.
Market Data 
Markets 
AI
